tiprankstipranks
Trending News
More News >

Jeffrey Farrow Insider Profile

4 Followers
Jeffrey Farrow, CFO at Hyperion Therapeutics, holds 36.70K shares in Tarsus Pharmaceuticals (Ticker: TARS), holds 26.74K shares in Global Blood Therapeutics (Ticker: GBT), holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX).
tipranks
Jeffrey Farrow

Jeffrey Farrow
Hyperion Therapeutics (HPTX)
CFO

Not Ranked
Ranked #52,567 out of 102,830 Corporate Insiders
Jeffrey Farrow has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Jeffrey Farrow's holdings

Insider Roles

Tarsus Pharmaceuticals
(TARS)
CFO and Chief Strategy Officer
Roles that Jeffrey Farrow holds in companies

Most Profitable Insider Trade

Stock:
Tarsus Pharmaceuticals
(TARS)
Rating:Informative Sell
Date:Mar 20, 2025 - Today
Return:+18.20%
The most profitable trade made by Jeffrey Farrow

Jeffrey Farrow's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HPTX
Hyperion Therapeutics
May 07, 2015
Uninformative Sell
6.64M
GBT
Global Blood Therapeutics
Jul 15, 2020
Uninformative Sell
1.14M
$1.83M
Tarsus Pharmaceuticals
Jun 18, 2025
CFO and Chief Strategy Officer
Uninformative Buy
589.33K
$1.76M
ZSPH
ZS Pharma
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Farrow's performance on stock

Jeffrey Farrow insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Farrow?
The percentage of profitable transactions made by Jeffrey Farrow is ―.
    What is the average return per transaction made by Jeffrey Farrow?
    The average return per transaction made by Jeffrey Farrow is ―.
      What stocks does Jeffrey Farrow hold?
      Jeffrey Farrow holds: HPTX, GBT, TARS, ZSPH stocks.
        What was Jeffrey Farrow’s latest transaction?
        Jeffrey Farrow latest transaction was an Uninformative Buy of $589.33K.
          What was Jeffrey Farrow's most profitable transaction?
          Jeffrey Farrow’s most profitable transaction was an Informative Sell of TARS stock on March 20, 2025. The return on the trade was 18.20%.
            What is Jeffrey Farrow's role in Hyperion Therapeutics?
            Jeffrey Farrow's role in Hyperion Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.